<DOC>
	<DOCNO>NCT00361933</DOCNO>
	<brief_summary>The purpose study learn whether people experience MCD ( multicentric Castleman 's Disease ) flare improve take valganciclovir . MCD type inflammatory disease associate Human Herpesvirus 8 ( HHV-8 ) . Valganciclovir FDA approve treat different type Human Herpesvirus , approve treatment HHV-8 . It therefore consider experimental study .</brief_summary>
	<brief_title>Valganciclovir Treat HHV-8 Associated Multicentric Castleman 's Disease</brief_title>
	<detailed_description>All participant undergo initial screening appointment . At visit , participant test Human Herpesvirus 8 ( HHV-8 ) , virus associate MCD , review participant ' medical history medical record determine whether he/she MCD . If participant live within Seattle area , visit may occur phone . Those qualify study follow 2 year . During 2 year period , participant ask collect oral swab week blood drawn monthly . If subject live within Seattle-area , ask ship sample UW test . We provide subject instruction shipment . This do cost participant . If 2 year period participant experience MCD flare , he/she admit University Washington Medical Center 's Clinic Research Center 14-days . If participant live within Seattle-area , travel expense cover . The study enroll total 8 patient receive open-label valganciclovir 14-days . Everyday hospitalization , participant blood drawn ( check HHV-8 level ) , 1 oral swab collect general physical exam perform .</detailed_description>
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Giant Lymph Node Hyperplasia</mesh_term>
	<mesh_term>Valganciclovir</mesh_term>
	<mesh_term>Ganciclovir</mesh_term>
	<criteria>Age 18 year Negative pregnancy test ( female participant ) Diagnosis MCD one year , history least one MCD recurrence annually Evidence infection HHV8 A willingness travel reside temporarily Seattle completion study protocol . For HIVinfected participant , stable antiretroviral regimen past 6 month Concurrent Kaposi sarcoma nonhodgkin 's lymphoma A history evidence CMV disease Hypersensitivity ganciclovir valganciclovir Use highdose acyclovir ( &gt; 800 mg bid ) , valacyclovir ( &gt; 1000 mg qd ) famciclovir ( &gt; 1000 mg qd ) , ganciclovir , foscarnet , cidofovir Neutropenia ( ANC &lt; 1500 ) Renal insufficiency serum creatinine &gt; 1.5 mg/ml CrCl &lt; 60 AST ALT &gt; 5 time upper limit normal Concurrent administration medication often associate severe neutropenia thrombocytopenia ( i.e. , chemotherapy , etc ) Concurrent administration probenecid didanosine . Inability read understand English</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2009</verification_date>
</DOC>